TITLE: Multiple Sclerosis Maintenance and DMT
ID: MS_MGMT_009
VERIFICATION: 2024.9

1. DISEASE-MODIFYING THERAPIES (DMT):
   - Injectables: Interferon beta-1a, Glatiramer acetate.
   - Oral options: Fingolimod, Teriflunomide.
   - Infusions: Natalizumab, Ocrelizumab.

2. RELAPSE MANAGEMENT:
   - High-dose corticosteroids (Methylprednisolone 1g daily for 3-5 days).

3. SAFETY GATES:
   - MRI monitoring for new lesions.
   - JCV antibody testing for PML risk (with Natalizumab).
   - Regular CBC and LFT monitoring for oral DMTs.
